B

Bio-Gene Technology Ltd
ASX:BGT

Watchlist Manager
Bio-Gene Technology Ltd
ASX:BGT
Watchlist
Price: 0.039 AUD -2.5% Market Closed
Market Cap: AU$11.9m

Bio-Gene Technology Ltd
Other Receivables

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Bio-Gene Technology Ltd
Other Receivables Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Receivables CAGR 3Y CAGR 5Y CAGR 10Y
B
Bio-Gene Technology Ltd
ASX:BGT
Other Receivables
AU$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Nufarm Ltd
ASX:NUF
Other Receivables
AU$94.7m
CAGR 3-Years
10%
CAGR 5-Years
-2%
CAGR 10-Years
N/A
Parkway Corporate Ltd
ASX:PWN
Other Receivables
AU$223.4k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Terragen Holdings Ltd
ASX:TGH
Other Receivables
AU$235.4k
CAGR 3-Years
-43%
CAGR 5-Years
-22%
CAGR 10-Years
N/A
Trigg Mining Ltd
ASX:TMG
Other Receivables
AU$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
R
RLF AgTech Ltd
ASX:RLF
Other Receivables
AU$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Bio-Gene Technology Ltd
Glance View

Market Cap
11.9m AUD
Industry
Chemicals

Bio-Gene Technology Ltd. is a development company enabling the next generation of novel insecticides, addressing the problems of insecticide resistance and toxicity. The company is headquartered in Melbourne, Victoria. The company went IPO on 2017-11-29. The Company’s principal activity is to develop and commercialize insecticide products. The company is focused on enabling novel insecticides to address the global problem of insecticide resistance and toxicity. Its novel platform technology is based on naturally occurring beta-triketones. The Company’s lead beta-triketone insecticide products include Flavocide and Qcide. Flavocide is a synthetically produced nature-identical compound. Testing of Flavocide has been undertaken and continues to be performed by both government research laboratories as well as by commercial collaborators. Qcide natural oil with high levels of tasmanone. The oil is extracted from the leaves of the Gympie Messmate, by utilizing a steam distillation process.

BGT Intrinsic Value
0.003 AUD
Overvaluation 92%
Intrinsic Value
Price AU$0.039
B

See Also

What is Bio-Gene Technology Ltd's Other Receivables?
Other Receivables
0 AUD

Based on the financial report for Dec 31, 2025, Bio-Gene Technology Ltd's Other Receivables amounts to 0 AUD.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett